Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 肺 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
怡然的涫完成签到,获得积分20
刚刚
marco完成签到 ,获得积分10
刚刚
wxywdd发布了新的文献求助10
刚刚
卿亦佳人完成签到,获得积分10
刚刚
1秒前
四时完成签到 ,获得积分10
1秒前
1秒前
wave完成签到,获得积分10
1秒前
山真页完成签到,获得积分10
1秒前
辛勤采柳发布了新的文献求助10
1秒前
2秒前
2秒前
2秒前
2秒前
keke完成签到,获得积分10
2秒前
莫愁完成签到,获得积分10
3秒前
爆米花的应助被believe采纳,获得10
3秒前
怡然的涫发布了新的文献求助20
4秒前
stpaaa完成签到 ,获得积分10
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
杨青黄完成签到,获得积分20
5秒前
Aurora发布了新的文献求助10
5秒前
Akim的应助被wpz采纳,获得10
5秒前
5秒前
Nole的应助被shiny采纳,获得10
5秒前
6秒前
Crssss发布了新的文献求助10
6秒前
wave发布了新的文献求助10
6秒前
CodeCraft的应助被淡淡新竹采纳,获得30
7秒前
7秒前
山真页发布了新的文献求助10
7秒前
小陈小陈完成签到,获得积分10
7秒前
雪白语海发布了新的文献求助10
7秒前
yy发布了新的文献求助10
8秒前
8秒前
lyj发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Das Matthäusevangelium: Kapitel 1:1–17 1000
Les Mots du discours 600
OREDA手册2009年第5版 500
A Consideration on Use of Material Grades for Hull Structural Members Based on Fracture Toughness(Second Report) 500
AI Disclosure in Annual Reports: Evolution, Determinants, and Capital Market Participants’ Perceptions 500
5th World Conference on Detergents: Reinventing the Industry : Opportunities and Challenges 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8113463
求助须知:如何正确求助?哪些是违规求助? 9520072
关于积分的说明 21527253
捐赠科研通 7691300
什么是DOI,文献DOI怎么找? 3412821
关于科研通互助平台的介绍 2539310
邀请新用户注册赠送积分活动 2452784